Psychedelics in Pain Management: Exploring Therapeutic Potential, Pharmacology, and Clinical Considerations

Preliminary evidence suggests that psychedelics, such as psilocybin, provide analgesic properties in chronic pain conditions. However, the mechanisms behind this and the therapeutic efficacy of psychedelics in pain management remains vastly understudied, with many studies citing difficulty in quantifying results due to unpredictable subjective dose intensity. In this edition of the Placebo Beyond Opinions Center guest lecture hybrid series, "Psychedelics in Pain Management: Exploring Therapeutic Potential, Pharmacology, and Clinical Considerations", they presented a panel of three distinguished speakers.

Participants include:
Andrew Coop, PhD
Maurizio Fava, MD
Patrick H. Finan, PhD
Luana Colloca, MD, PhD